Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats

Endocrinology

Volumn 138, Issue 4, 1997, Pages 1585-1591

  Thomas, Gregory B ^a   Fairhall, Keith M ^a   Robinson, Iain C A F ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; GROWTH HORMONE; PEPTIDE HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; CONTROLLED STUDY; CORTICOSTERONE RELEASE; FEEDBACK SYSTEM; GROWTH HORMONE RELEASE; GROWTH INHIBITION; HORMONE ACTION; HORMONE RESPONSE; HYPOPHYSECTOMY; HYPOPHYSIS ADRENAL SYSTEM; NONHUMAN; PEPTIDE SYNTHESIS; PEPTIDERGIC NERVOUS SYSTEM; PRIORITY JOURNAL; RAT;

EID: 0030909925     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.4.5065     Document Type: Article

References (45)

1. Bowers CY, Veeraragavan K, Sethumadhavan K 1994 Atypical growth hormone peptides. In: Bercu BB, Walker RF (eds) Growth Hormone II: Basic and Clinical Aspects. Springer-Verlag, New York, pp 203-222
2. Smith RG, Cheng K, Schoen WR, Pong SS, Hickey G, Jacks T, Butler B, Chan W, Chaung L, Judith F, Taylor J, Wyvratt MJ, Fisher MH 1993 A nonpeptidyl growth-hormone secretagogue. Science 260:1640-1643
3. Gertz BJ, Barrett JS, Eisenhandler R, Krupa DA, Wittreich JM, Seibold JR, Schneider SH 1993 Growth hormone response in man to L-692,429, a novel nonpeptide mimic of growth hormone-releasing peptide-6. J Clin Endocrinol Metab 77:1393-1397
4. Pong S-S, Chaung L-YP, Dean DC, Nargund RP, Patchett AA, Smith RG 1996 Identification of a new G-protein-linked receptor for growth hormone secretagogues. Mol Endocrinol 10:57-61
5. Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, Hamelin MJ, Hreniuk DL, Palyha OC, Anderson J, Paress PS, Diaz C, Chou M, Liu K, McKee KK, Pong S-S, Chaung L-Y, Elbrecht A, Dashkevicz M, Heavens R, Rigby M, Sirinathsinghji DJS, Dean DC, Mellio DG, Patchett AA, Nargund R, Griffin PR, De Martino JA, Gupta SK, Schaeffer JM, Smith RG, Van der Ploeg LHT 1996 A receptor in the pituitary and hypothalamus that functions in growth hormone release. Science 273:974-977
6. Bowers CY, Momany F, Reynolds GA, Hong A 1984 On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology 114:1537-1545
7. Bowers CY, Sartor AO, Reynolds GA, Badger TM 1991 On the actions of the growth hormone-releasing hexapeptide, GHRP. Endocrinology 128:2027-2035
8. Clark RG, Carlsson LMS, Trojnar J, Robinson ICAF 1989 The effects of a growth hormone-releasing peptide and growth hormone-releasing factor in conscious and anaesthetized rats. J Neuroendocrinol 1:249-255
9. 2 on growth hormone (GH)-re-leasing factor-stimulated GH release and intracellular adenosine 3′,5′-monophosphate accumulation in rat primary pituitary cell culture. Endocrinology 124:2791-2798
10. Bowers CY, Reynolds GA, Durham D, Barrera CM, Pezzoli SS, Thorner MO 1990 Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone. J Clin Endocrinol Metab 70:975-982
11. Frieboes RM, Murck H, Maier P, Schier T, Holsboer F, Steiger A 1995 Growth hormone-releasing peptide-6 stimulates sleep, growth hormone, ACTH and cortisol release in normal man. Neuroendocrinology 61:584-589
12. Hickey G, Jacks T, Judith F, Taylor J, Schoen WR, Krupa D, Cunningham P, Clark J, Smith RG 1994 Efficacy and specificity of L-692,429, a novel nonpeptidyl growth-hormone secretagogue, in beagles. Endocrinology 134:695-701
13. Chang CH, Rickes EL, McGuire L, Cosgrove S, Taylor J, Chen H, Feighner S, Clark JN, de Vita R, Schoen W, Wyvratt M, Fisher M, Smith RG, Hickey GJ 1995 Activity of a novel nonpeptidyl growth hormone secretagogue, L-700,653, in swine. Endocrinology 136:1065-1071
14. Jacks T, Hickey G, Judith F, Taylor J, Chen H, Krupa D, Feeney W, Schoen W, Ok D, Fisher M, Wyvratt M, Smith R 1994 Effects of acute and repeated intravenous administration of L-692,585, a novel-peptidyl growth hormone secretagogue, on plasma growth hormone, IGF-1, ACTH, Cortisol, prolactin, insulin, and thyroxine levels in beagles. J Endocrinol 143:399-406
15. Hickey GJ, Drisko J, Faidley T, Chang C, Anderson LL, Nicolich S, McGuire L, Rickes E, Krupa D, Feeney W, Friscino B, Cunningham P, Frazier E, Chen H, Laroque P, Smith RG 1996 Mediation by the central nervous system is critical to the in vivo activity of the GH secretagogue L-692,585. J Endocrinol 148:371-380
16. Schleim K-D, Jacks T, Cunningham P, Feeney W, Frazier EG, Niebauer GW, Zhang D, Chen H, Smith RG, Hickey G, Effect of MK-677 on growth hormone, ICF-1 and cortisol in beagles before and after hypophysectomy. 10th International Congress of Endocrinology, San Francisco CA, 1996 (Abstract P1-603)
17. Cheng K, Chan WWS, Butler B, Wei L, Smith RG 1993 A novel non-peptidyl growth hormone secretagogue. Horm Res 40:109-115
18. Elias KA, Ingle GS, Burnier JP, Hammonds RG, McDowell RS, Rawson TE, Somers TC, Stanley MS, Cronin MJ 1995 In vitro characterization of four novel classes of growth hormone-releasing peptide. Endocrinology 136:5694-5699
19. Massoud AF, Hindmarsh PC, Pringle PJ, Brook CGD, Low dose hexarelin and GHRH leads to massive GH release without significant effects on cortisol and prolactin. 10th International Congress of Endocrinology, San Francisco CA, 1996 (Abstract P1-593)
20. Guillaume V, Magnan E, Cataldi M, Dutour A, Sauze N, Renard M, Razafindraibe H, Contedevolx B, Deghenghi R, Lenaerts V, Oliver C 1994 Growth-hormone (GH)-releasing hormone-secretion is stimulated by a new GH-releasing hexapeptide in sheep. Endocrinology 135:1073-1076
21. Antoni FA 1986 Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of a 41-residue corticotropin releasing factor. Endocr Rev 7:351-378
22. Rivier C, Vale W 1983 Interaction of corticotropin-releasing factor and arginine vasopressin on adrenocorticotropin secretion in vivo. Endocrinology 113:939-942
23. Thomas GB, Fairhall KM, Robinson ICAF, GH, ACTH and corticosterone responses to GHRP-6, CRF and AVP in conscious rats. 10th International Congress of Endocrinology, San Francisco CA, 1996 (Abstract P1-592)
24. Clark RG, Robinson ICAF 1985 Growth hormone (GH) responses to multiple injections of a fragment of human GH-releasing factor in conscious male and female rats. J Endocrinol 106.281-289
25. Clark RG, Chambers G, Lewin J, Robinson ICAF 1986 Automated repetitive microsampling of blood: growth hormone secretion in conscious male rats. J Endocrinol 111:27-35
26. Kovacs KJ, Antoni FA 1990 Atriopeptin inhibits stimulated secretion of adrenocorticotropin in rats: evidence for a pituitary site of action. Endocrinology 127:3003-3008
27. Keller-Wood M, Dallman M 1984 Corticosteroid inhibition of ACTH secretion. Endocr Rev 5:1-24
28. Voltz DM, Piering AW, Magestro M, Giustina A, Wehrenberg WB 1995 Effect of GHRP-6 and GHRH on GH secretion in rats following chronic glucocorticoid treatment. Life Sci 56:491-497
29. Gertz BJ, Sciberras DG, Yogendran I Christie K, Bador K, Krupa D, Wittreich JM, James I 1994 L-692,429, a novel nonpeptide growth hormone (GH) secretagogue, reverses glucocorticoid suppression of GH secretion. J Clin Endocrinol Metab 79:745-749
30. Leal-Cerro A, Pumar A, Garcia-Garcia E, Dieguez C, Casanueva FF 1994 Inhibition of growth hormone release after the combined administration of GHRH and GHRP-6 in patients with Cushing's syndrome. Clin Endocrinol (Oxf) 42:649-654
31. Giustina A, Bussi AR, Deghenghi R, Imbimbo B, Licini M, Poiesi C, Wehrenberg WB 1995 Comparison of the effects of growth-releasing hormone and hexarelin, a novel growth hormone-releasing peptide-6 analog, on growth hormone secretion in humans with or without glucocorticoid excess. J Endocrinol 146:227-232
32. Wehrenberg WB, Janowski B, Piering AW, Culler F, Jones KL 1990 Glucocorticoids: potent inhibitors and stimulators of growth hormone secretion. Endocrinology 126:3200-3203
33. Giustina A, Wehrenberg WB 1992 The role of glucocorticoids in the regulation of growth hormone secretion: mechanisms and clinical significance Trends Endocrinol Metab 3:306-311
34. Fairhall KM, Mynett A, Robinson ICAF 1995 Central effects of growth hormone-releasing hexapeptide (GHRP-6) on growth hormone release are inhibited by central somatostatin action. J Endocrinol 144:555-560
35. Swanson LW, Sawchenko PE, Rivier J, Vale WW 1983 Organization of ovine corticotropin-releasing factor immunoreactive cells and fibres in the rat brain: an immunohistochemical study. Neuroendocrinology 36:165-186
36. Dickson SL, Leng G, Robinson ICAF 1993 Systemic administration of growth hormone-releasing peptide activates hypothalamic arcuate neurons. Neuroscience 53:303-306
37. Dickson SL, Luckman SM 1997 Induction of c-fos mRNA in neuropeptide Y and growth hormone-releasing hormone neurones in the rat arcuate nucleus following systemic injection of the growth hormone secretagogue, GHRP-6. Endocrinology 138: 771-777
38. Baker RA, Herkenham M 1995 Arcuate nucleus neurons that project to the hypothalamic paraventricular nucleus; neuropeptidergic identity and consequences of adrenalectomy on mRNA levels in the rat. J Comp Neurol 358:518-530
39. Rivier C, Vale W 1984 Corticotropin-releasing factor (CRF) acts centrally to inhibit growth hormone secretion in the rat. Endocrinology 114:2409-2411
40. Katakami J, Arimura A, Frohman LA 1985 Involvement of hypothalamic somatostatin in the suppression of growth hormone secretion by central corticotropin-releasing factor in conscious male rats. Neuroendocrinology 41:390-393
41. Holsboer F, von Bardeleben U, Steiger A 1988 Effects of intravenous corticotropin-releasing hormone upon sleep-related growth hormone surge and sleep EEG in man. Neuroendocrinology 48:32-38
42. Hisano S, Daikoku S 1991 Existence of mutual synaptic relations between corticotropin-releasing factor-containing and somatostatin-containing neurons in the rat hypothalamus. Brain Res 545:265-275
43. Peterfreund RA, Vale WW 1983 Ovine corticotropin-releasing factor stimulates somatostatin secretion from cultured brain cells. Endocrinology 112:1275-1278
44. McDowell RS, Elias KA, Stanley MS, Burdick DJ, Burnier JP, Chan KS, Fairbrother WJ, Hammonds RG, Ingle GS, Jacobsen NE, Mortensen DL, Rawson TE, Won WB, Clark RG, Somers TC 1995 Growth hormone secretagogues: Characterization, efficacy, and minimal bioactive conformation. Proc Natl Acad Sci USA 92:11165-11169
45. Copinschi G, Van Onderbergen A, L'Hermite-Baleriaux M, Mendel CM, Caufriez A, Leproult R, Bologenese JA, De Smet M, Thorner MO, Van Cauter E1996 Effects of a 7-day treatment with a novel, orally active, growth hormone (GH) secretagogue, MK-677, on 24-hour GH profiles, insulin-like growth factor I, and adrenocortical function in normal young men. J Clin Endocrinol Metab 81:2776-2782